The Good Friday and Easter holidays are over, and everyone is back on track in an increasingly positive way. Even Eric who went to sunny Jacksonville, FL for the week and ate out almost the entire time was able to stay in the “non-diabetic” zone #’s which he said was a miracle (when Eric is back home and has a chance to post his data we will update the chart for this week and last week). We are all here to share with you our “real world” experience, the good days and bad days. For those of us on CGM’s, each measurement was taken every 5 minutes, 24 hours a day, 7 days a week = 2,016 monitoring calculations per person per week. You can tell every single one of us has tremendously improved our diabetes control in only 4 weeks of reporting this–it does continue to get better and better. When each of us reach the end of our individual 12 weeks or so on Afrezza and see our respective doctor for an official A1C test, we will be posting our OFFICIAL A1c results for the world to see. Based on results so far, it will be truly “UNBELIEVABLE” (thank you Dr. Bode of Atlanta Diabetes Ctr. for those words already–just wait until we each have 90 full days on Afrezza-I can’t wait to hear what you will say next!).
What surprises you most about the fourth week data?
The biggest surprise for me was how well Jackie who has about six weeks of experience really “dialed it in” this week–She achieved a “Personal Best” with every single zone, and also was able to attain a correlated A1C level of 5.28 (ie. non-diabetic) which she has never done. When you look at her Dexcom monitor postings on twitter (@IM_TypeOne) you can see she has mastered in a very short period of time, how the drug Afrezza works best for her body. I applaud you Jackie for helping and encouraging other diabetics to get tighter control and not settle for mediocre diabetes management. You will be one of the original heroes who was willing to show everyone that anyone with practice can improve their results.
At the same time, I would like to introduce Laureen to everyone. She has been a T1D since 1983 and like Brian also has experience with Exubera. Both have relayed to me how well Afrezza works so much better, faster, easier, etc. that perhaps a future blog article will be written about this! Lauren has faced hurdles with her insurance company to be on Afrezza, and is glad to contribute and share her knowledge with everyone–thank you so much Laureen!
Next week or so I will reformat the chart and post weekly comparisons but for now it should be so obvious that Afrezza works, especially in looking at the week 4 data! Add in all the conveniences from discreet, anywhere use, pain-free inhalation vs. needles, ultra rapid effectiveness and Afrezza shows it’s superiority. Also, the A1C’s levels we are running at now are considered “non-diabetic” or “pre-diabetic”. Of course, this number needs to be run for 12 weeks before any of the participants can claim an A1C in 5’s or low 6’s. You should know that none of us have ever had an A1c that low. We are all stunned, as will our doctors be when we do get that 3 month A1C number. Note: Dr. Bode did look at my data from my Dexcom Monitor and it was only for the first 4 weeks and used the word “unbelievable” several times. On the trials I finished with an A1C of 7.1 even with all the protocols. Can’t wait to see other doctors reaction around the country when all the Afrezza users officially report their A1C’s – doctors will be shocked. Let the revolution begin…
What is the Afrezza Users “Real Life” Results Group?
It is a group of Afrezza Users who use a Continuous Glucose Monitors (Type 1’s) seeking tighter diabetes control and measuring the time spent in each blood sugar range. This week we are adding a new trusted user who like most diabetics uses “finger prick” measurements throughout her day to measure her blood glucose levels. For her (Laureen) we will take an average blood glucose per day (which is an average of approximately 7 or more daily finger pricks). It is NOT a competition and was only started so people could understand and see the inherent benefit of why Afrezza provides better control and higher patient satisfaction for t1 and t2 diabetics over our previous regimens.
Why are you doing this?
There has been so much discussion about the FDA Afrezza Drug trials and why I feel as a participant in the Affinity 1 trial, there were significant “hold backs” as to why we were not able to materially outperform Injectable Insulin because of the protocols on the trials. This is no longer the case!
To Summarize just a few of the hold backs why Afrezza didn’t get to show it’s metal:
- Afrezza Dosing only changed approx. every 6 weeks, and not flexible dosing depending on meal
- No CGM’s allowed
- Time in Zone not measured
- Patient quality of life not measured
- Brand new Afrezza users vs. Very experienced Injectable users (what if it was brand new injectable users vs. experienced Afrezza users—would that be fair? No-they would stop the trial right away because it would be a TKO/referee stops contest victory for Afrezza which we are proving by real world experience.)
What would you like to express to everyone out there considering Afrezza or to any doctors considering prescribing Afrezza for their patients?
My opinion is that Afrezza is a “life-changing” drug that is not very well understood by the diabetic community at large—both doctors and patients. It improved my life and gave me hope in treating my diabetes. I would wish the same for any other diabetic out there—a better and higher quality of life!